NCT03015857View on ClinicalTrials.gov

Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Adverse Anesthesia Outcome
Interventions
DRUG

phenylephrine

\- phenylephrine; a vasopressor drug given to prevent post spinal hypotension

DRUG

Norepinephrine

\- norepinephrine; a vasopressor drug given to prevent post spinal hypotension

DRUG

Bupivacaine

intrathecal bupivacaine 10 mg will be given in both groups

DRUG

Fentanyl

intrathecal fentanyl 20 mcg will be given in both groups

DRUG

Placebo (normal saline)

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT03015857 - Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension | Biotech Hunter | Biotech Hunter